Interleukin-17, a salivary biomarker for COVID-19 severity.

Fatemeh Saheb Sharif-AskariNarjes Saheb Sharif-AskariShirin HafeziBushra MdkhanaHawra Ali Hussain AlsayedAbdul Wahid AnsariBassam MahboubAdel M ZakeriMohamad-Hani TemsahWalid ZahirQutayba HamidRabih Halwani

Published in: PloS one (2022)

We propose that saliva IL-17 level could be used as a biomarker to identify patients at risk of developing severe COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
drug induced